November 26 Omicron variant news

By Melissa Mahtani, Aditi Sangal Adrienne Vogt and Fernando Alfonso, CNN

Updated 0542 GMT (1342 HKT) November 27, 2021
1 Post
Sort byDropdown arrow
11:21 a.m. ET, November 26, 2021

A new Covid-19 variant is spreading in South Africa. Here's what we know.

David McKenzie and Ghazi Balkiz

Scientists work on the COVID-19 at the Centre for Epidemic Response and Innovation in KwaZulu-Natal, South Africa. Prof Tulio de Oliveira, the director of the Centre for Epidemic Response and Innovation in South Africa, said there was an unusual constellation of mutations and that it was very different to other variants that have circulated. In a media briefing Prof de Oliveira said there were 50 mutations overall and more than 30 on the spike protein
Scientists work on the COVID-19 at the Centre for Epidemic Response and Innovation in KwaZulu-Natal, South Africa. Prof Tulio de Oliveira, the director of the Centre for Epidemic Response and Innovation in South Africa, said there was an unusual constellation of mutations and that it was very different to other variants that have circulated. In a media briefing Prof de Oliveira said there were 50 mutations overall and more than 30 on the spike protein (Eyepress/Reuters)

South Africa's health minister announced Thursday the discovery of a new coronavirus variant that appears to be spreading rapidly in parts of the country.

"Initially, it looked like some cluster outbreaks, but from yesterday, the indication came from our scientists from the Network of Genomic Surveillance that they were observing a new variant," Minister of Health Joe Phaahla said, stressing that it is currently unclear where the variant – currently dubbed B.1.1.529 – first emerged.

It has so far been detected in South Africa, Botswana and in a traveler to Hong Kong from South Africa, Phaahla added.

During a news briefing, genomic scientists said the variant has an unusually high number of mutations, with more than 30 in the key spike protein – the structure the virus uses to get into the cells they attack.

Professor Tulio de Oliveira, the director of the Center for Epidemic Response and Innovation, said the variant has "many more mutations than we have expected," adding it is "spreading very fast and we expect to see pressure in the health system in the next few days and weeks."

He advised the public to "try to avoid super spreading events."

Officials also expressed concern that the mutation could result in immune evasion and enhanced transmissibility of the virus, but added it is too early to tell what kind of impact the mutations will have on vaccine efficacy. More studies also need to be conducted to understand the clinical severity of the variant compared to previous variants, officials said.

"The full significance of this variant remains uncertain and the best tool we have is still the vaccines," De Oliveira said. He added that lab studies still need to be carried out to test vaccine and antibody evasion.

CNN's Duarte Mendonca contributed to this report.